Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)

Mangoceuticals Says MGX-0024 Cuts H5N1 Deaths and Eliminates Respiratory Mortality in Poultry Trials

Mangoceuticals Inc - Mortality Reduced by up to 60% in Pre-Treatment Group

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Asian Equities Traded in the US as American Depositary Receipts Start Week Slightly Higher in Monday Trading

Mangoceuticals Shares Rise 81% on Strong Sales of Injectable Testosterone Therapy

Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today

Srx Health Solutions Increases Ownership of Opendoor Technologies by 30% and Is NOW Net Long Cryptocurrency Holdings

SRx Health Solutions Raises Opendoor Stake by 30% and Turns Net Long Crypto Holdings

NYSE American issues warning letter to SRx Health Solutions for listing and shareholder approval violations

Srx Health Solutions Announces Receipt of Warning Letter From Nyse American

AITX Expands RAD RIO Mini Deployments With Repeat Order

BUZZ-Mangoceuticals surges on strong sales of injectable testosterone therapy

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Guardian Pharmacy Services Hosts Annual Sales and Account Management Meeting in Atlanta

GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)